Daiichi Sankyo Co Ltd (4568) – Strategy, SWOT and Corporate Finance Report
- Pages: 71
- Published: July 2023
- Report Code: MLPH5751FSA
Daiichi Sankyo Co Ltd (4568) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Daiichi Sankyo Co Ltd (Daiichi Sankyo) is a holding company, which carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over the counter (OTC) drugs, vaccines, and others. Its portfolio encompasses medicines for cardiovascular, neurological, nephrological, diabetic, metabolic, and infectious diseases, and various types of cancers. Besides cancer, the company’s other research areas include rare diseases and immune disorders. Daiichi Sankyo sells its products through its group companies and an extensive network of medical representatives. It has operations in North America, South and Central America, Europe, and Asia. Daiichi Sankyo is headquartered in Tokyo, Japan.
Scope
• Detailed information on Daiichi Sankyo Co Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Daiichi Sankyo Co Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Daiichi Sankyo Co Ltd including a breakdown and examination of key business segments
• News about Daiichi Sankyo Co Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Daiichi Sankyo Co Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Daiichi Sankyo Co Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Daiichi Sankyo Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Chugai Pharmaceutical Co Ltd
Kaken Pharmaceutical Co Ltd
Merck & Co Inc
Shionogi & Co Ltd
Taisho Pharmaceutical Holdings Co Ltd
Chugai Pharmaceutical Co Ltd
Kaken Pharmaceutical Co Ltd
Merck & Co Inc
Shionogi & Co Ltd
Takeda Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Taisho Pharmaceutical Holdings Co Ltd
Sumitomo Pharma Co Ltd
Modulus Discovery Inc
Astellas Pharma Inc
Takeda Pharmaceutical Co Ltd
Modulus Discovery Inc
Astellas Pharma Inc
Mitsubishi Tanabe Pharma Corp
Sumitomo Pharma Co Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.